Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference

Rhea-AI Summary

Singular Genomics Systems (Nasdaq: OMIC) will present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Florida. The presentation is scheduled for Wednesday, June 12, 2024, at 7:40 a.m. PT / 10:40 a.m. ET. Management will participate in a fireside chat, and a live and recorded webcast will be available at investor.singulargenomics.com. Singular Genomics leverages novel next-generation sequencing (NGS) and spatial multiomics technologies to support researchers and clinicians.

Positive

• Singular Genomics' participation in a prestigious event like the Goldman Sachs Global Healthcare Conference may increase investor confidence and visibility.
• Offering a live and recorded webcast ensures broader accessibility for interested parties.
• The company's focus on NGS and spatial multiomics technologies positions it at the forefront of innovative research solutions.

Negative

• No direct mention of financial performance or specific business milestones in the announcement, which might leave investors seeking concrete data unsatisfied.

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced plans to present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Florida.

Singular Genomics’ management is scheduled to participate in a fireside chat Wednesday, June 12, 2024, at 7:40 a.m. Pacific Time / 10:40 a.m. Eastern Time. Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation at investor.singulargenomics.com in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4® Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In addition, the company is currently developing the G4X™ Spatial Sequencer, which will leverage Singular’s proprietary sequencing technology, applying it as an in situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.

Investor Contact
Philip Trip Taylor
Gilmartin Group
ir@singulargenomics.com  

Media Contact
Matt Browning
pr@singulargenomics.com

FAQ

When will Singular Genomics present at the Goldman Sachs Global Healthcare Conference?

Singular Genomics will present on June 12, 2024, at 7:40 a.m. PT / 10:40 a.m. ET.

Where can I watch the Singular Genomics presentation?

The presentation can be watched live or as a recorded webcast at investor.singulargenomics.com in the Presentations & Events section.

What technologies does Singular Genomics specialize in?

Singular Genomics specializes in next-generation sequencing (NGS) and spatial multiomics technologies.

How might Singular Genomics' presentation at the Goldman Sachs Conference impact OMIC stock?

Participation in high-profile events could increase investor interest and visibility, potentially impacting OMIC stock positively.